Rationale and feasibility of a rapid integral biomarker program that informs immune-oncology clinical trials: the ADVISE trial. [PDF]
Luke JJ+13 more
europepmc +1 more source
Independent validation and outlier analysis of EuroPOND alzheimer's disease staging model using ADNI and real-world clinical data. [PDF]
Wittens MMJ+28 more
europepmc +1 more source
The diagnostic utility of urinary 5-HIAA and leucine-rich alpha-2 glycoprotein in acute appendicitis: a narrative review. [PDF]
Baig Y, Mohammed A, Butler AE.
europepmc +1 more source
Neurodegenerative Biomarkers in Multiple Sclerosis: At the Interface Between Research and Clinical Practice. [PDF]
Ciubotaru A+10 more
europepmc +1 more source
Change in serum biomarker levels in patients of apical periodontitis after root canal treatment using two different root canal sealers: A randomized controlled trial. [PDF]
Sharma J+5 more
europepmc +1 more source
Baseline type 2 biomarker levels and clinical remission predictors in children with asthma. [PDF]
Chen M+6 more
europepmc +1 more source
Clinical outcomes of DNA-damaging agents and DNA damage response inhibitors combinations in cancer: a data-driven review. [PDF]
Fontenot R+5 more
europepmc +1 more source
MicroRNAs in Preeclampsia: An Overview of Biomarkers and Potential Therapeutic Targets. [PDF]
Oancea M+8 more
europepmc +1 more source
Obesity Biomarkers: Exploring Factors, Ramification, Machine Learning, and AI-Unveiling Insights in Health Research. [PDF]
Awari A+8 more
europepmc +1 more source